Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder
Cruceanu C, Alda M, Grof P, Rouleau GA, Turecki G.PLoS One. 2012;7(2):e32680. AbstractBipolar disorder (BD) is a debilitating psychiatric condition with a prevalence of 1-2% in the general population that is characterized by severe episodic shifts in mood ranging from depressive to manic episodes. One of the most common treatments is lithium (Li), with successful […]